JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258941

Human LARP4B knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

LARP4B KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 149 bp insertion in exon2.

View Alternative Names

A630096F19, AI256361, D13Wsu64e, KIAA0217, LAR4B_HUMAN, LARP5, La ribonucleoprotein domain family member 4B, La ribonucleoprotein domain family member 5, La-related protein 4B, La-related protein 5, MGC78318

1 Images
Sanger Sequencing - Human LARP4B knockout HeLa cell lysate (AB258941)
  • Sanger seq

Unknown

Sanger Sequencing - Human LARP4B knockout HeLa cell lysate (AB258941)

Homozygous : 149 bp insertion in exon2

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 149 bp insertion in exon2.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258941-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human LARP4B knockout HeLa cell lysate", "number":"AB258941-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB258941-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
LARP4B
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

LARP4B also known as La-related protein 4B is a protein of approximately 78 kDa. It is expressed in various tissues but shows higher expression in testis and liver. The protein contains an RNA-binding domain which indicates its role in RNA metabolism. LARP4B interacts with mRNA influencing its stability and translation. This protein belongs to the LARP family which is known for involvement in RNA-binding processes.
Biological function summary

LARP4B plays a role in regulating mRNA stability and translation. It often cooperates with mRNA decay and translation initiation factors. LARP4B does not form a stable complex but associates transiently with other RNA-binding proteins to perform its function. Its ability to bind mRNA suggests involvement in gene expression post-transcriptionally impacting various cellular processes.

Pathways

LARP4B is implicated in the mTOR signaling pathway and the RNA processing pathway. The mTOR pathway is essential for cell growth and proliferation linking nutrient availability to these processes. LARP4B works in tandem with other proteins like LARP1 and EIF4E to modulate mRNA stability indirectly influencing cell growth through translation regulation.

LARP4B has a connection to cancer and neurological disorders. Abnormal expression of LARP4B has been observed in certain cancers suggesting a role in tumorigenesis. In neurological disorders differences in LARP4B expression levels have been associated with disease progression. The protein establishes a relationship with LARP1 in cancer contexts further exploring how altered mRNA translation contributes to these diseases.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com